Cyltezo(adalimumab-adbm), the First Interchangeable Biosimilar to Humira
The US FDA has approved the first interchangeable biosimilar product to treat…
Jyseleca (filgotinib), approved in the EU for the treatment of adults with moderate to severe rheumatoid arthritis
Jyseleca is a medicine for treating adults with moderate to severe rheumatoid…
New indication for Olumiant (baricitinib) as oral treatment for moderate to severe atopic dermatitis
EMA has recommended granting an extension of indication to Olumiant…